Ligand · VMA
VMA · 1-methyl-5-phenyl-6-{[(1R)-1-(pyridin-2-yl) ethyl]sulfanyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
VMA, 1-methyl-5-phenyl-6-{[(1R)-1-(pyridin-2-yl) ethyl]sulfanyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (C19 H17 N5 O S, 363.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- VMA
- Formula
- C19 H17 N5 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VMA in 2 structures; the first of them:
- 7JWU · Crystal structure of human ALDH1A1 bound to compound (R)-28 · VMA A606 · binds SER121, GLY125, THR129, PHE171, MET175, TRP178, TYR297, CYS302 and 6 more
- 7JWU · Crystal structure of human ALDH1A1 bound to compound (R)-28 · VMA A606 · binds SER121, GLY125, THR129, PHE171, MET175, TRP178, TYR297, CYS302 and 6 more
Residues it binds most
GLY 2, PHE 2, SER 2, ALA 2, CYS 2, ILE 2, MET 2, THR 2, TRP 2, TYR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.